As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Moderator(s)

Robert A. Hauser, MD, MBA

Professor of Neurology, Molecular Pharmacology, and Physiology; Director, USF Health Byrd Parkinson's Disease and Movement Disorders Center of Excellence, National Parkinson Foundation Center of Excellence, Tampa, Florida

Disclosures

Disclosure: Robert Hauser, MD, MBA, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie Inc.; Allergan, Inc.; Auspex Pharmaceuticals; AstraZeneca Pharmaceuticals LP; Biotie Therapies Corp; Ceregene; Chelsea Therapeutics, Inc.; Cleveland Clinic; GE Healthcare; Gerson Lehrman Group; GLG Pharma, LLC; HealthLogiX; IMPAX Laboratories, Inc.; Indus Pharma; Ipsen; Lilly; Lundbeck, Inc.; Merck & Co., Inc.; Merck Sharp & Dohme Corp.; Noven Pharmaceuticals, Inc.; Pfizer Inc; Pricespective; Strakan Pharmaceuticals Ltd; Targacept, Inc.; Teva Neuroscience, Inc.; Teva Pharmaceuticals USA; UCB Pharma, Inc.; Upsher-Smith Laboratories, Inc.; US WorldMeds, LLC; XenoPort, Inc.; Zambon Company SpA

Dr Hauser does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Hauser does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Panelists

Horacio Kaufmann, MD

Professor of Neurology and Medicine; Director, Dysautonomia Center, New York University Langone Medical Center, New York, New York

Disclosures

Disclosure: Horacio Kaufmann, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Lundbeck, Inc.

Dr Kaufmann does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Kaufmann does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

William B. White, MD

Professor and Division Chief, Pat and Jim Calhoun Cardiology Center, University of Connecticut Health Center, Farmington, Connecticut

Disclosures

Disclosure: William B. White, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP; Roche; Takeda Pharmaceuticals North America, Inc.

Dr White does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr White does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

Ronald K. Miller, PhD

Scientific Director, Medscape, LLC

Disclosures

Disclosure: Ronald K. Miller, PhD, has disclosed no relevant financial relationships.

CME Reviewer(s)

Nafeez Zawahir, MD

CME Clinical Director, Medscape, LLC

Disclosures

Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

CME

Neurogenic Orthostatic Hypotension: Expert Perspectives on Diagnosis and Treatment Strategies

Authors: Robert Hauser, MD, MBA; Horacio Kaufmann, MD; William B. White, MD
CME Released: 12/4/2014; Reviewed and Renewed: 5/18/2016
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 5/18/2017

Start Activity

Target Audience and Goal Statement

This activity is intended for neurologists, primary care providers, cardiologists, nurses, and pharmacists who care for patients with autonomic disturbances.

The goal of this activity is to improve physicians' knowledge and competency in diagnosing and designing appropriate treatment regimens for patients with neurogenic orthostatic hypotension (nOH).

Upon completion of this activity, participants will be able to:

Identify patients at higher risk for nOH and list the factors that elevate risk
Discuss the diagnostic criteria and patient presentation for nOH
Evaluate the evidence for available and emerging treatments for nOH to integrate new therapies into patient management strategies

Disclosures

Moderator(s)

Robert A. Hauser, MD, MBA

Professor of Neurology, Molecular Pharmacology, and Physiology; Director, USF Health Byrd Parkinson's Disease and Movement Disorders Center of Excellence, National Parkinson Foundation Center of Excellence, Tampa, Florida

Disclosures

Disclosure: Robert Hauser, MD, MBA, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie Inc.; Allergan, Inc.; Auspex Pharmaceuticals; AstraZeneca Pharmaceuticals LP; Biotie Therapies Corp; Ceregene; Chelsea Therapeutics, Inc.; Cleveland Clinic; GE Healthcare; Gerson Lehrman Group; GLG Pharma, LLC; HealthLogiX; IMPAX Laboratories, Inc.; Indus Pharma; Ipsen; Lilly; Lundbeck, Inc.; Merck & Co., Inc.; Merck Sharp & Dohme Corp.; Noven Pharmaceuticals, Inc.; Pfizer Inc; Pricespective; Strakan Pharmaceuticals Ltd; Targacept, Inc.; Teva Neuroscience, Inc.; Teva Pharmaceuticals USA; UCB Pharma, Inc.; Upsher-Smith Laboratories, Inc.; US WorldMeds, LLC; XenoPort, Inc.; Zambon Company SpA

Dr Hauser does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Hauser does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Panelists

Horacio Kaufmann, MD

Professor of Neurology and Medicine; Director, Dysautonomia Center, New York University Langone Medical Center, New York, New York

Disclosures

Disclosure: Horacio Kaufmann, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Lundbeck, Inc.

Dr Kaufmann does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Kaufmann does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

William B. White, MD

Professor and Division Chief, Pat and Jim Calhoun Cardiology Center, University of Connecticut Health Center, Farmington, Connecticut

Disclosures

Disclosure: William B. White, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP; Roche; Takeda Pharmaceuticals North America, Inc.

Dr White does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr White does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

Ronald K. Miller, PhD

Scientific Director, Medscape, LLC

Disclosures

Disclosure: Ronald K. Miller, PhD, has disclosed no relevant financial relationships.

CME Reviewer(s)

Nafeez Zawahir, MD

CME Clinical Director, Medscape, LLC

Disclosures

Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Accreditation Statements

For Physicians

Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Neurology & Neurosurgery

CME

Neurogenic Orthostatic Hypotension: Expert Perspectives on Diagnosis and Treatment Strategies

Authors: Robert Hauser, MD, MBA; Horacio Kaufmann, MD; William B. White, MDFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME Released: 12/4/2014; Reviewed and Renewed: 5/18/2016

Valid for credit through: 5/18/2017

processing....

Abbreviations

BP = blood pressure
DA = dopamine
DDC = dopa decarboxylase
EOS = end of study
FDA = Food and Drug Administration
MSA = multiple system atrophy
NE = norepinephrine
nOH = neurogenic orthostatic hypotension
OH = orthostatic hypotension
OHQ = Orthostatic Hypotension Questionnaire
PD = Parkinson disease
PSP = progressive supranuclear palsy

« Return to: Neurogenic Orthostatic Hypotension: Expert Perspectives on Diagnosis and Treatment Strategies

CME Information Download Slides

PDF Downloads

Web Reprint

Print
Like Tweet

References

Faculty and Disclosures

Moderator(s)

Robert A. Hauser, MD, MBA

Panelists

Horacio Kaufmann, MD

William B. White, MD

Editor(s)

Ronald K. Miller, PhD

CME Reviewer(s)

Nafeez Zawahir, MD

CME

Neurogenic Orthostatic Hypotension: Expert Perspectives on Diagnosis and Treatment Strategies

Target Audience and Goal Statement

Disclosures

Moderator(s)

Robert A. Hauser, MD, MBA

Panelists

Horacio Kaufmann, MD

William B. White, MD

Editor(s)

Ronald K. Miller, PhD

CME Reviewer(s)

Nafeez Zawahir, MD

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Neurogenic Orthostatic Hypotension: Expert Perspectives on Diagnosis and Treatment Strategies

Abbreviations

PDF Downloads